PUBLIC COMPANY
saveAlcyone Therapeutics Inc
updated 5mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Biogen CEO tells analysts he’s focused on early-stage R&D as ‘we were not very good with that’Biogen's CEO has pointed to the company's ability to take five drugs into clinical trials so far this year as evidence of its new focus on early-stage R&D.fiercebiotech · 17d ago
- ‘We have what we need to grow:’ Biogen CEO happy to ease off the M&A for a whileBiogen's business development team may have been busy in recent years, but CEO Christopher Viehbacher is easing off the acquisitions for a while.fiercebiotech · 3mo ago
Data sources
Found something off?
comments(0)
5-min edit window · permanent after that